Company patents
Curium US LLC
Curium US LLC's patent strategy reveals a strong and rapidly accelerating focus on Pharmaceutical Preparations, which constitutes 73.7% of its portfolio and saw a remarkable 111.1% year-over-year growth in 2025. Surprisingly, despite its core pharma focus, the company also maintains a significant 42.1% of its portfolio in Compounds Containing Metals, which experienced an 80.0% growth in 2025, indicating a dual emphasis on both pharmaceutical development and the underlying material science, though patenting activity so far in 2026 shows a sharp decline in both categories.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
57 US filings (since 2023) · 5 categories · 4 themes
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Methods and apparatuses for creating unique package structures, such as recesses in specific materials, blister packages, or single-dose units, and for controlled dispensing of products from storage into these containers.
Large-scale processes for synthesizing, purifying, or recycling various industrial metal compounds, including sulphides, hydroxides, and sulfates, often involving chemical reactions, crystallization, or electromembrane processes.
Design and synthesis of acyclic or carbocyclic organic compounds that selectively modulate specific biological targets or pathways for the treatment of diseases.
Patents
Showing 1-6 of 6
Specialized Container Forming & Dispensing